Psychedelic Drugs Market 2030 By Source (Natural Psychedelic Drugs and Synthetic Psychedelic Drugs), Drug Type (Gamma Hydroxybutyric Acid (GHB), Ketamine, Psilocybin, and Others), Distribution Channel and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits

Industry : Healthcare | Pages : 180 Pages | Published On : Dec 2023

The Psychedelic Drugs Market size is estimated to grow from USD 3.6 Billion in 2022 to reach USD 4.6 Billion by 2030, growing at a CAGR of 13.5% during the forecast period from 2023 to 2030.

Major players Psychedelic Drugs Market include: Jazz Pharmaceuticals, Inc., Janssen Pharmaceuticals, Pfizer Inc., Verrian, Avadel, Celon Pharma S.A., COMPASS, F. Hoffmann-La Roche Ltd, Hikma Pharmaceuticals PLC, NeuroRx, Inc., PharmaTher Inc., Mind Medicine, Inc., Cybin Corp., GABA Therapeutics, Inc., EmpathBio, DemeRx and Others.

The Growth of Psychedelic Drugs Market Driven by Growing recognition of the potential therapeutic benefits of psychedelic substances

The Psychedelic Drugs Market is being driven by various key factors. Firstly, there is a growing recognition of the potential therapeutic benefits of psychedelic substances. In recent years, there has been a renewed interest in studying these drugs for their ability to treat mental health conditions such as depression, anxiety, PTSD, and addiction. The positive outcomes observed in clinical trials and research studies have gained support and acceptance from the medical and scientific communities. Secondly, some governments and regulatory agencies in certain regions are open to exploring the medical use of psychedelic drugs. This changing regulatory landscape has created opportunities for companies to invest in research and development, leading to the expansion of the psychedelic drugs market. Additionally, there is a notable increase in public awareness and advocacy efforts for mental health, which has resulted in a growing demand for alternative and innovative treatments. As a result, many patients and healthcare providers are seeking options beyond traditional pharmaceuticals, contributing to the market growth of psychedelic drugs. The combination of these factors has led to a surge in investments, research activities, and the development of psychedelic-based treatments, ultimately driving the growth of the psychedelic drugs market. However, it's essential to consider that regulations, social perceptions, and ongoing research will continue to shape the future of this market.

Rising Awareness Towards Mental Health

Raising awareness about mental illness has become essential as it negatively affects people's ability to live a normal life. This includes educating the public about the various causes, related disorders, and treatment options available. Many organizations and companies are actively launching campaigns and initiatives to increase awareness, empowering patients to make informed decisions regarding their specific condition and symptoms. The use of advertisements and awareness campaigns has also played a role in promoting the recognition of psychedelic drugs as potential treatments for mental health conditions. Consequently, the growing awareness towards mental health is anticipated to be a driving force behind the expansion of the psychedelic drugs market.

North America Dominated the Psychedelic Drugs Market during the forecast period.

In 2022, the North American region is poised to dominate the global psychedelic drugs market, driven by several factors. These include a surge in research and development activities in the psychedelic field, a growing emphasis on mental health treatment, and an increase in the prevalence of mental health disorders. The rising awareness surrounding the potential use of psychedelic drugs for treating mental health conditions is expected to further propel market growth. Moreover, the expansion of companies and the establishment of new psychedelic treatment centers are set to make significant contributions to the overall market growth in the region. The increasing incidence of mental disorders, coupled with focused awareness campaigns promoting psychedelic drug therapy for mental health issues, as well as the introduction of new psychedelic drug products, will likely lead to substantial market growth in North America during the forecast period.

On the other hand, Europe plays a crucial role in the increasing demand for psychedelic drugs, securing the second position globally. Among European countries, Germany stands out as a significant player in this market. The growing global population has also contributed to the escalating demand for hallucinogenic substances. Both private enterprises and government entities have invested significantly in new drug research and development, driving the European psychedelic drugs market to prominence. As the prevalence of mental illness continues to rise, individuals and governments alike are becoming more conscious of their health and well-being. This heightened awareness has led to a greater understanding of the potential benefits of psychedelic drugs in mental health treatment, further contributing to the significance of the European market in this domain.

Psychedelic Drugs Market Scope and Market Size

Analysis

Details

Report Forecast Period

2023-2030

Base Year

2022

CAGR Values

13.5%

Projection Values in 2022

USD 3.6 Billion

Projection Values in 2028

USD 4.6 Billion

Segment covered

Source, Drug Type, Indication, Form, Route of Administration, End-user, Distribution Channel and Region

Region

North America, Latin America, Europe, Asia-Pacific, Middle East & Africa

The Psychedelic Drugs Market research report provides an in-depth overview of the industry including market segmentation by Source, Drug Type, Indication, Form, Route of Administration, End-user, Distribution Channel and Region. Analysis of the global market with special focus on high growth application in each vertical and fast-growing market segments. It includes detailed competitive landscape with identification of the key players with respect to each type of market, in-depth market share analysis with individual revenue, market shares, and top players rankings. Impact analysis of the market dynamics with factors currently driving and restraining the growth of the market, along with their impact in the short, medium, and long-term landscapes. Competitive intelligence from the company profiles, key player strategies, game-changing developments such as new product launch, collaborations, expansions, investment analysis, mergers and acquisitions.

Psychedelic Drugs Market is segmented by region and further by countries, Source, Drug Type, Indication, Form, Route of Administration, End-user, Distribution Channel and Region. Players, stakeholders, and other participants in the global Psychedelic Drugs Market will be able to gain a strong position as this report will surely benefit their marketing strategies. The market analysis focuses on revenue and forecast by region/countries and by application in terms of revenue forecast for the period 2023-2030.

Report further studies the market strategies of key players, recent development status, future plans and Psychedelic Drugs Market trends across the world. Also, it splits Psychedelic Drugs Market Segmentation by material, end-user and region to deep dive research and reveals company profile and prospects.

Major Classifications are as follows:

  • By Source
    • Natural Psychedelic Drugs
    • Synthetic Psychedelic Drugs
  • By Drug Type
    • Gamma Hydroxybutyric Acid (GHB)
    • Ketamine
    • Psilocybin
    • Lysergic Acid Diethylamide (LSD)
    • 3,4-MethylEnedioxyMethamphetamine
    • Others
  • By Indication
    • Depressive Disorders
    • Post-Traumatic Stress Disorders
    • Substance Abuse Disorders
    • Obsessive Compulsive Disorders
    • Alzheimer Dementia
    • Cluster Headaches
    • Others
  • By Form
    • Liquid
    • Capsules
    • Tablets
  • By Route of Administration
    • Oral Psychedelic Drugs
    • Injectable Psychedelic Drugs
      • Intramuscular
      • Subcutaneous
      • Intrathecal
    • Rectal Psychedelic Drugs
    • Nasal Psychedelic Drugs
    • Transdermal Psychedelic Drugs
  • By End-user
    • Hospital
    • Speciality Clinics
    • Homecare
    • Others
  • By Distribution Channel
    • Online Pharmacies
    • Hospital Pharmacies
    • Institutional Sales
    • Retail Sales
    • Retail pharmacies
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Rest of Asia Pacific
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • Israel
      • South Africa
      • Rest of Middle East & Africa      

Reason to purchase this Psychedelic Drugs Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global Psychedelic Drugs Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different and Psychedelic Drugs Market segments in the top spending countries across the world and identify the opportunities offered by each of them.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global Psychedelic Drugs Market, providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Psychedelic Drugs Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Psychedelic Drugs Market providers around the world which include information about their products, alliances, recent contract wins and financial analysis wherever available.

TOC

  1. Executive Summary
  2. Introduction
    1. Key Takeaways
    2. Report Description
    3. Market Scope & Definition
    4. Stakeholders
  3. Research Methodology
      1. Market size
      2. Key data points from primary sources
      3. Key data points from secondary sources
      4. List of primary sources
      5. List of secondary sources
  4. Market Overview
    1. Introduction
    2. Industry Segmentation
    3. Market Trends Analysis
    4. Major Funding & Investments
    5. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
    6. Value Chain Analysis
  5. Psychedelic Drugs Market, By Source
    1. Introduction
    2. Natural Psychedelic Drugs
    3. Synthetic Psychedelic Drugs
  6. Psychedelic Drugs Market, By Drug Type
    1. Introduction
    2. Gamma Hydroxybutyric Acid (GHB)
    3. Ketamine
    4. Psilocybin
    5. Lysergic Acid Diethylamide (LSD)
    6. 3,4-MethylEnedioxyMethamphetamine
    7. Others
  7. Psychedelic Drugs Market, By Indication 
    1. Introduction
    2. Depressive Disorders
    3. Post-Traumatic Stress Disorders
    4. Substance Abuse Disorders
    5. Obsessive Compulsive Disorders
    6. Alzheimer Dementia
    7. Cluster Headaches
    8. Others
  8. Psychedelic Drugs Market, By Form 
    1. Introduction
    2. Liquid
    3. Capsules
    4. Tablets
  9. Psychedelic Drugs Market, By Route of Administration
    1. Introduction
    2. Oral Psychedelic Drugs
    3. Injectable Psychedelic Drugs
      1. Intramuscular
      2. Subcutaneous
      3. Intrathecal
    4. Rectal Psychedelic Drugs
    5. Nasal Psychedelic Drugs
    6. Transdermal Psychedelic Drugs
  10. Psychedelic Drugs Market, By End-user
    1. Introduction
    2. Hospital
    3. Speciality Clinics
    4. Homecare
    5. Others
  11. Psychedelic Drugs Market, By Distribution Channel
    1. Introduction
    2. Online Pharmacies
    3. Hospital Pharmacies
    4. Institutional Sales
    5. Retail Sales
    6. Retail pharmacies
  12. Psychedelic Drugs Market, By Geography
    1. North America
      1. U.S.
      2. Canada
    2. Latin America
      1. Brazil
      2. Mexico
      3. Argentina
      4. Rest of Latin America
    3. Europe
      1. UK
      2. Germany
      3. France
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    4. Asia Pacific
      1. China
      2. Japan
      3. India
      4. South Korea
      5. Rest of Asia Pacific
    5. Rest of the world (RoW)
      1. Middle East
        1. UAE
        2. Saudi Arabia
        3. Israel
      2. Africa
        1. South Africa
        2. Rest of Africa
  13. Competitive Landscapes
    1. Introduction
    2. Top Companies Ranking
    3. Market Share Analysis
      1. Competition Dashboard
      2. Market Share Analysis (2022)
      3. Emerging company case studies
    4. Company Profiles
      1. Jazz Pharmaceuticals, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      2. Janssen Pharmaceuticals
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      3. Pfizer Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
        6. Rewards & Recognition
      4. Pfizer Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      5. Avadel
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      6. Celon Pharma S.A.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      7. COMPASS
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      8. F. Hoffmann-La Roche Ltd
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      9. Hikma Pharmaceuticals PLC
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      10. NeuroRx, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      11. PharmaTher Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      12. Mind Medicine, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      13. Cybin Corp.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      14. GABA Therapeutics, Inc.
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      15. EmpathBio
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition
      16. DemeRx
        1. Business Overview
        2. Product Portfolio
        3. Market Segments (Business Segment/Region)
        4. Sales Footprint
        5. Recent Developments
          1. New Product Launch
          2. Mergers & Acquisitions
          3. Collaborations, Partnerships & Agreements
          4. Rewards & Recognition

Table and Figures

Methodology:

At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Choose License Type
PERSONALIZE THIS RESEARCH TO BE CHANGED TO
  • Tailored advice to Drive your Performance
  • Product Planning Strategy
  • New Product Stratergy
  • Expanded Research Scope
  • Comprehensive Research
  • Strategic Consulting
  • Provocative and pragmatic
  • Accelerate Revenue & Growth
  • Evaluate the competitive landscape
  • Optimize your partner network
  • Analyzing industries
  • Mapping trends
  • Strategizing growth
  • Implementing plans
REQUEST A FREE CUSTOMIZATION
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)

Email: sales@marketdigits.com